Application Nr Approved Date Route Status External Links
NDA021779 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indications And Usage Ventavis® Is A Prostacyclin Mimetic Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1) To Improve A Composite Endpoint Consisting Of Exercise Tolerance, Symptoms (Nyha Class), And Lack Of Deterioration. Studies Establishing Effectiveness Included Predominately Patients With Nyha Functional Class Iii-Iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah (65%) Or Pah Associated With Connective Tissue Diseases (23%). ( 1.1 ). 1.1 Pulmonary Arterial Hypertension Ventavis® Is Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1) To Improve A Composite Endpoint Consisting Of Exercise Tolerance, Symptoms (Nyha Class), And Lack Of Deterioration. Studies Establishing Effectiveness Included Predominately Patients With Nyha Functional Class Iii–iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah (65%) Or Pah Associated With Connective Tissue Diseases (23%) [See Clinical Studies (14) ] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Iloprost ILOPROST ZINC3784120

Comments